Research shows semaglutide — commonly sold as Ozempic or Wegovy — can improve kidney function and survival rates for people ...

2026 study of nearly 15,000 people found the best time to exercise for your heart is earlier than most people think.

The first study of its kind to compare cardiovascular risk in type 1 diabetes (T1D) and type 2 diabetes (T2D) in both men and women shows that younger men with T2D have worse mortality and ...

A deep dive into lipid genetics reveals how ancestry-specific molecular pathways could be driving higher diabetes and heart disease risk, bringing researchers closer to more precise, ...

A new study in the European Heart Journal shows that people who develop type 1 diabetes in adulthood have an increased risk of cardiovascular disease and death, and that those diagnosed later in life ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. When people think of diabetes, they often focus on blood ...

Transformative treatment reducing cardiovascular risk in diabetes; The STUMBL Score; SID-Cymru; Finding the answer to improved reconstructi ...

GLP-1 therapies help control blood sugar. Beyond this, research shows that these medications can reduce the risk of major ...

Time to clinical benefit was assessed. The x-axis represents time from randomization, and the y-axis represents the degree of benefit at that time, as measured by the hazard ratio shown in blue. The ...

Scientists are digging into why heart disease risk in type 2 diabetes differs between men and women—and sex hormones may be part of the story. In a large Johns Hopkins study, men with higher ...

Insulin resistance can develop for years without a single noticeable symptom - and by the time it does show up, the path ...